Urine myo-inositol as a novel prognostic biomarker for diabetic kidney disease: a targeted metabolomics study using nuclear magnetic resonance.
Soie KwonJin Seong HyeonYoungae JungLilin LiJung Nam AnYong Chul KimSeung Hee YangTammy KimDong Ki KimChun Soo LimGeum-Sook HwangJung Pyo LeePublished in: Kidney research and clinical practice (2023)
Myo-inositol can be used as an additive biomarker of ESRD progression in DKD.